Literature DB >> 19282843

Pathogenic anti-desmoglein MAbs show variable ELISA activity because of preferential binding of mature versus proprotein isoforms of desmoglein 3.

Preety M Sharma, Eun Jung Choi, Keiko Kuroda, Takahisa Hachiya, Ken Ishii, Aimee S Payne.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19282843      PMCID： PMC2841796          DOI： 10.1038/jid.2009.41

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  9 in total

1.  Dominant autoimmune epitopes recognized by pemphigus antibodies map to the N-terminal adhesive region of desmogleins.

Authors:  M Sekiguchi; Y Futei; Y Fujii; T Iwasaki; T Nishikawa; M Amagai
Journal:  J Immunol       Date:  2001-11-01       Impact factor: 5.422

2.  Novel insights into cadherin processing by subtilisin-like convertases.

Authors:  Horst Posthaus; Claire M Dubois; Eliane Müller
Journal:  FEBS Lett       Date:  2003-02-11       Impact factor: 4.124

3.  Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins.

Authors:  K Ishii; M Amagai; R P Hall; T Hashimoto; A Takayanagi; S Gamou; N Shimizu; T Nishikawa
Journal:  J Immunol       Date:  1997-08-15       Impact factor: 5.422

Review 4.  Pemphigus, bullous impetigo, and the staphylococcal scalded-skin syndrome.

Authors:  John R Stanley; Masayuki Amagai
Journal:  N Engl J Med       Date:  2006-10-26       Impact factor: 91.245

5.  Genetic and functional characterization of human pemphigus vulgaris monoclonal autoantibodies isolated by phage display.

Authors:  Aimee S Payne; Ken Ishii; Stephen Kacir; Chenyan Lin; Hong Li; Yasushi Hanakawa; Kazuyuki Tsunoda; Masayuki Amagai; John R Stanley; Don L Siegel
Journal:  J Clin Invest       Date:  2005-04       Impact factor: 14.808

6.  Isolation of pathogenic monoclonal anti-desmoglein 1 human antibodies by phage display of pemphigus foliaceus autoantibodies.

Authors:  Ken Ishii; Chenyan Lin; Don L Siegel; John R Stanley
Journal:  J Invest Dermatol       Date:  2007-11-15       Impact factor: 8.551

7.  Use of autoantigen-knockout mice in developing an active autoimmune disease model for pemphigus.

Authors:  M Amagai; K Tsunoda; H Suzuki; K Nishifuji; S Koyasu; T Nishikawa
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

8.  Pathogenic epitopes of autoantibodies in pemphigus reside in the amino-terminal adhesive region of desmogleins which are unmasked by proteolytic processing of prosequence.

Authors:  Mariko Yokouchi; Marwah Adly Saleh; Keiko Kuroda; Takahisa Hachiya; John R Stanley; Masayuki Amagai; Ken Ishii
Journal:  J Invest Dermatol       Date:  2009-04-02       Impact factor: 8.551

9.  The role of intramolecular epitope spreading in the pathogenesis of endemic pemphigus foliaceus (fogo selvagem).

Authors:  Ning Li; Valeria Aoki; Gunter Hans-Filho; Evandro A Rivitti; Luis A Diaz
Journal:  J Exp Med       Date:  2003-05-27       Impact factor: 14.307
  9 in total
  14 in total

Review 1.  Pemphigus: a Comprehensive Review on Pathogenesis, Clinical Presentation and Novel Therapeutic Approaches.

Authors:  Robert Pollmann; Thomas Schmidt; Rüdiger Eming; Michael Hertl
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

2.  ER-to-Golgi blockade of nascent desmosomal cadherins in SERCA2-inhibited keratinocytes: Implications for Darier's disease.

Authors:  Ning Li; Moonhee Park; Shengxiang Xiao; Zhi Liu; Luis A Diaz
Journal:  Traffic       Date:  2017-02-28       Impact factor: 6.215

Review 3.  Setting the target for pemphigus vulgaris therapy.

Authors:  Christoph T Ellebrecht; Aimee S Payne
Journal:  JCI Insight       Date:  2017-03-09

4.  Pemphigus autoantibodies generated through somatic mutations target the desmoglein-3 cis-interface.

Authors:  Giovanni Di Zenzo; Giulia Di Lullo; Davide Corti; Valentina Calabresi; Anna Sinistro; Fabrizia Vanzetta; Biagio Didona; Giuseppe Cianchini; Michael Hertl; Rudiger Eming; Masayuki Amagai; Bungo Ohyama; Takashi Hashimoto; Jerry Sloostra; Federica Sallusto; Giovanna Zambruno; Antonio Lanzavecchia
Journal:  J Clin Invest       Date:  2012-09-04       Impact factor: 14.808

5.  Temporal Outcomes after Rituximab Therapy for Pemphigus Vulgaris.

Authors:  Napatra Tovanabutra; Christina E Bax; Rui Feng; Carolyn J Kushner; Aimee S Payne
Journal:  J Invest Dermatol       Date:  2021-10-26       Impact factor: 8.551

6.  Autoimmune reactivity against precursor form of desmoglein 1 in healthy Tunisians in the area of endemic pemphigus foliaceus.

Authors:  Amina Toumi; Marwah Adly Saleh; Jun Yamagami; Olfa Abida; Maryem Kallel; Abderrahmen Masmoudi; Sondes Makni; Hamida Turki; Takahisa Hachiya; Keiko Kuroda; John R Stanley; Hatem Masmoudi; Masayuki Amagai
Journal:  J Dermatol Sci       Date:  2013-02-19       Impact factor: 4.563

7.  Desmocollin 3-mediated binding is crucial for keratinocyte cohesion and is impaired in pemphigus.

Authors:  Volker Spindler; Wolfgang-Moritz Heupel; Athina Efthymiadis; Enno Schmidt; Rüdiger Eming; Christian Rankl; Peter Hinterdorfer; Thomas Müller; Detlev Drenckhahn; Jens Waschke
Journal:  J Biol Chem       Date:  2009-08-28       Impact factor: 5.157

Review 8.  Immune response in pemphigus and beyond: progresses and emerging concepts.

Authors:  Giovanni Di Zenzo; Kyle T Amber; Beyza S Sayar; Eliane J Müller; Luca Borradori
Journal:  Semin Immunopathol       Date:  2015-11-23       Impact factor: 9.623

9.  Pathogenic epitopes of autoantibodies in pemphigus reside in the amino-terminal adhesive region of desmogleins which are unmasked by proteolytic processing of prosequence.

Authors:  Mariko Yokouchi; Marwah Adly Saleh; Keiko Kuroda; Takahisa Hachiya; John R Stanley; Masayuki Amagai; Ken Ishii
Journal:  J Invest Dermatol       Date:  2009-04-02       Impact factor: 8.551

10.  Serological diagnosis of autoimmune bullous skin diseases: prospective comparison of the BIOCHIP mosaic-based indirect immunofluorescence technique with the conventional multi-step single test strategy.

Authors:  Nina van Beek; Kristin Rentzsch; Christian Probst; Lars Komorowski; Michael Kasperkiewicz; Kai Fechner; Inga M Bloecker; Detlef Zillikens; Winfried Stöcker; Enno Schmidt
Journal:  Orphanet J Rare Dis       Date:  2012-08-09       Impact factor: 4.123
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.